India — Whole Grains, Milled Grain Products, and Starch

← back to leaderboard

India received 267 FDA import refusals in Whole Grains, Milled Grain Products, and Starch between 2023-Q4 and 2026-Q3. Volume peaked at 43 in 2024-Q1, with the trend falling sharply year-on-year. The most-cited issues are pesticide, salmonella, and mfr insan. No trade baseline is published for this commodity from India, so no per-$1B rate is shown here.

Of these, 254 were hazard refusals and 13 were paperwork refusals.

Exporting from India? Get an email when shipments from India are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

40 2023-Q4 2023-Q4: 40 43 2024-Q1 2024-Q1: 43 24 2024-Q2 2024-Q2: 24 37 2024-Q3 2024-Q3: 37 25 2024-Q4 2024-Q4: 25 26 2025-Q1 2025-Q1: 26 9 2025-Q2 2025-Q2: 9 27 2025-Q3 2025-Q3: 27 10 2025-Q4 2025-Q4: 10 8 2026-Q1 2026-Q1: 8 11 2026-Q2 2026-Q2: 11 7 2026-Q3 2026-Q3: 7

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Wheat 32 305.2 pesticide
Rice 227 89.3 pesticide
Grains-Starch-Other 7 pesticide
Maize-Corn 2 mycotoxin

Recent rejections